Turkmenistan Medical Device Registration: Language Strategy for Dossiers and Labeling
Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
The language arrangements in Turkmenistan can be characterized as lenient for the dossier and strict for labels, with three languages in play:
- Registration dossier: may be submitted in Russian, Turkmen and/or English;
- Instructions for use and packaging labels: may be submitted in Turkmen and/or Russian and/or English, but must be approved by the competent authority (approved / registered);
- Certain documents must be translated into Russian: the following 6 categories of documents require a Russian translation, namely the cover letter, the application form, the CPP or country-of-origin registration certificate, the GMP certificate, the summary of product quality characteristics, and the finished product quality control methods.
The practical conclusion is that the dossier can be predominantly in English, but the instructions for use, the labels and the key annexes must land in Russian or Turkmen. Companies that discover the Russian translation obligations late in the project routinely lose weeks, because translation, technical review and, in some cases, re-layout of artwork all sit between the discovery and a submissible file. The language matrix should therefore be fixed at the start of the project, not improvised at the point of submission.
2. Legal basis
| Legal instrument | Number / identifier | Publication date | Provisions |
|---|---|---|---|
| Law of Turkmenistan on the Supply of Medicines | No. 319-V | January 12, 2016 | National registration procedure and documentation requirements |
| Regulation on National Registration of Medicines and Medical Devices | No public number (approved by the Ministry of Health) | Current version | Dossier languages; list of documents to be translated into Russian; approval of instructions for use and labels |
| Law of Turkmenistan on Certification | No public number (law) | Current version | Turkmen language labeling requirements for imported products |
Three instruments jointly govern language. The registration Regulation determines which languages the dossier may use and which documents must be accompanied by Russian translations, and it makes approval of the instructions for use and labels an act of the competent authority. The Law on Certification, operating in the mandatory certification system, adds its own Turkmen language expectations for imported goods. The two frameworks must be read separately, because their language requirements are not identical.
3. Expert insights
Insight 1: an English dossier is permitted, and it is also a trap.
Because the dossier may be submitted in English, many companies opt for an all-English dossier. But the system simultaneously requires the cover letter, the application form, the CPP or registration certificate, the GMP certificate and the other listed documents to be accompanied by Russian translations. The result is often a hybrid of an English dossier with Russian annexes, and without unified planning the preliminary review will require the missing translations to be supplied. The fix is organizational rather than linguistic: one person owns the language matrix, every document in the index carries a language tag, and the six mandatory Russian translations are produced alongside their source documents rather than after them.
Insight 2: approval of the instructions for use and labels is substantive technical review.
The instructions for use and the labels are not documents that are simply attached; they must be approved by the competent authority. This means that every claim, every symbol and every formatting element on the label may be required to change. It is advisable to schedule the finalization of the instructions for use and the labels late, leaving room for at least one round of revisions. Artwork locking too early is one of the most common self-inflicted delays, because a single reviewer comment on a symbol or a claim forces a reprint, a re-translation and a re-submission of the affected pages.
Insight 3: Turkmen is the sole official language, but Russian is the practical lingua franca.
Turkmen is the only state language of Turkmenistan; Russian is widely used in the cities and is the explicitly required language for the dossier translations. The practical strategy therefore is: Russian first, with Turkmen as a complement on the label side. Article 26 expands on the specific label arrangements. Bilingual labeling that pairs Russian with Turkmen generally satisfies both the registration side and the certification side, but the exact combination should be confirmed case by case with the competent authority.
Insight 4: the Law on Certification places stronger emphasis on Turkmen.
In the mandatory certification (TDS) system, the marking requirements for imported goods packaging list Turkmen as a core language. This is not fully aligned with the three-language option on the registration side. The two systems differ subtly in their language requirements, and each must be confirmed separately. A label that passes registration review may still fail a certification marking check, or the reverse, which is why the two frameworks should never be assumed to substitute for one another.
Insight 5: translation quality is a recurring source of deficiency letters.
Industry sources repeatedly mention cases in which poor translation quality caused applications to be returned and processes to be delayed by months. The Russian rendering of technical terms must correspond strictly to the source text, especially performance parameters, warnings and instructions for operation. It is advisable to have the translation done by a Russian translator with a medical background and reviewed by the manufacturer’s technical staff. Building a bilingual term base at project start, covering device names, anatomical terms and safety warnings, pays for itself many times over during review.
4. Practical recommendations
- Define the language matrix of an English dossier with Russian annexes, and mark the language of every document in the dossier index.
- List the documents requiring Russian translation early, and complete translation and proofreading in a single coordinated batch.
- Leave one revision window for the instructions for use and labels, and schedule their finalization late in the project.
- Have technical terminology handled by a translator with a medical background, followed by technical review by the manufacturer.
- Confirm the language requirements of the registration side and the certification side separately, and do not apply one to the other.
5. Verification checklist
- □ The language matrix has been defined and the language of every document is marked in the index.
- □ The list of documents requiring Russian translation has been drawn up and the translations have been proofread.
- □ The instructions for use and labels have a reserved revision window.
- □ Technical translations have been produced by a translator with a medical background and technically reviewed.
- □ The language requirements of the registration side and the certification side have been confirmed separately.
Regulatory information verified as of October 30, 2026. The content of this document was checked against Law No. 319-V on the Supply of Medicines (January 12, 2016) and the Regulation on National Registration of Medicines and Medical Devices approved by the Ministry of Health (dossier languages, list of documents to be translated into Russian, approval of instructions for use and labels); the requirement of the Law on Certification for Turkmen language marking of imported goods packaging forms a separate framework and must be confirmed separately.
- Local resources in Turkmenistan: GRZAN can coordinate licensed local import entities and authorized representative resources, covering national registration submission, the consular legalization chain for documents, sample delivery, interfaces with mandatory TDS certification, and customs clearance support.
- Service scope: classification determination, selection of the registration pathway, preparation of national-format dossiers, consular legalization and notarization, preparation of testing and stability documentation, organization of GMP and ISO 13485 evidence, changes and renewal, vigilance and post-market maintenance.
- Contact: GRZAN supports manufacturers, importers and authorized representatives with registration in this country; reach us at info@grzanglobal.com.
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us